Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
21-Apr-2025 | 549.9 | 553.9 | 538 | 540.75 | 8,604 | 11,33,78,567.3 | 97,911 |
22-Apr-2025 | 541.8 | 548.85 | 528.95 | 531.1 | 13,709 | 16,17,68,474.8 | 1,20,364 |
23-Apr-2025 | 534.9 | 540.7 | 518.75 | 531.55 | 13,566 | 19,33,54,118.95 | 1,38,706 |
24-Apr-2025 | 530 | 544.9 | 530 | 532.5 | 10,733 | 12,40,61,412.25 | 84,907 |
25-Apr-2025 | 532.05 | 534 | 507.75 | 517.05 | 14,008 | 16,60,65,499.7 | 1,23,460 |
28-Apr-2025 | 512 | 521.15 | 506.15 | 513.75 | 12,450 | 11,80,83,075.5 | 75,175 |
29-Apr-2025 | 514.9 | 520.85 | 505.65 | 509.95 | 8,089 | 8,13,01,708.25 | 58,192 |
30-Apr-2025 | 510 | 517 | 500.6 | 506.2 | 9,046 | 10,78,75,747.65 | 90,550 |
02-May-2025 | 517.7 | 517.7 | 502.4 | 506.45 | 9,317 | 9,39,11,998.85 | 74,464 |
05-May-2025 | 509.8 | 510.95 | 497 | 505.6 | 8,265 | 7,17,14,618.6 | 53,537 |
06-May-2025 | 510 | 537.75 | 488 | 495 | 28,722 | 35,83,70,876.3 | 1,94,642 |
07-May-2025 | 488 | 499.9 | 481.1 | 495.1 | 9,175 | 9,63,74,918.75 | 72,344 |
08-May-2025 | 495.9 | 506.3 | 480 | 483.75 | 9,812 | 9,30,33,339.05 | 65,477 |
09-May-2025 | 477 | 489 | 475 | 485.8 | 10,243 | 8,46,43,615.95 | 53,689 |
12-May-2025 | 500 | 514 | 496.05 | 510.6 | 16,114 | 18,92,05,693.1 | 1,64,569 |
13-May-2025 | 514.35 | 549.6 | 507.65 | 545.45 | 22,752 | 37,21,59,416.35 | 2,40,867 |
14-May-2025 | 547.8 | 558.4 | 535.9 | 541.05 | 18,717 | 30,85,83,676.4 | 2,60,250 |
15-May-2025 | 542 | 550.9 | 532.25 | 540.5 | 23,112 | 31,75,60,448.8 | 2,34,314 |
16-May-2025 | 511.95 | 518 | 491 | 496.1 | 36,974 | 54,18,64,612.65 | 5,11,633 |
19-May-2025 | 501 | 518.4 | 499.15 | 513.25 | 12,757 | 22,04,58,808.55 | 2,12,899 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
